Breakthrough blood-testing technology to speed analysis and diagnosis
At Ativa, we are developing the world’s first MicroLAB, so clinicians can diagnose and treat acute conditions more reliably and faster than ever before. Our revolutionary fluid processing engine will consolidate the most common medical test families and provides results within minutes.
And we’re almost there.
- We hold the necessary patents, and are backed by major investors and partners, including three global Fortune 100 companies and five global 500 companies.
- A mature quality system is in place in preparation for our upcoming FDA submission and ISO certification.
- Initial clinical studies, including one with a major U.S. hospital, are completed and show strong results.
- We are preparing to begin clinical trials for our first FDA 510(k) submission.
- And the medical technology community recognizes our promise, including naming us one of three finalists for the AACC’s Disruptive Technology Award.
Learn more about our breakthrough technology.
Contact us to learn more.